MX2008016503A - Uso de inhibidores de hdac para el tratamiento de linfomas. - Google Patents

Uso de inhibidores de hdac para el tratamiento de linfomas.

Info

Publication number
MX2008016503A
MX2008016503A MX2008016503A MX2008016503A MX2008016503A MX 2008016503 A MX2008016503 A MX 2008016503A MX 2008016503 A MX2008016503 A MX 2008016503A MX 2008016503 A MX2008016503 A MX 2008016503A MX 2008016503 A MX2008016503 A MX 2008016503A
Authority
MX
Mexico
Prior art keywords
treatment
lymphomas
hdac inhibitors
hdac inhibitor
cutaneous
Prior art date
Application number
MX2008016503A
Other languages
English (en)
Inventor
Peter Wisdom Atadja
Wenlin Shao
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2008016503A publication Critical patent/MX2008016503A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al uso de un inhibidor de HDAC, especialmente un inhibidor de HDAC de la fórmula (I), en donde los radicales y símbolos tienen los significados definidos en la descripción, para la preparación de un medicamento para el tratamiento de enfermedades linfoproliferativas, en particular, linfomas de células T cutáneos.
MX2008016503A 2006-06-28 2007-06-26 Uso de inhibidores de hdac para el tratamiento de linfomas. MX2008016503A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80602606P 2006-06-28 2006-06-28
PCT/US2007/014985 WO2008002634A1 (en) 2006-06-28 2007-06-26 Use of hdac inhibitors for the treatment of lymphomas

Publications (1)

Publication Number Publication Date
MX2008016503A true MX2008016503A (es) 2009-06-08

Family

ID=38617341

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008016503A MX2008016503A (es) 2006-06-28 2007-06-26 Uso de inhibidores de hdac para el tratamiento de linfomas.

Country Status (6)

Country Link
US (2) US20090281159A1 (es)
CA (1) CA2654936A1 (es)
EE (1) EE200800070A (es)
MX (1) MX2008016503A (es)
TR (1) TR200809829T1 (es)
WO (1) WO2008002634A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002015921A2 (en) * 2000-08-18 2002-02-28 The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor
IL160970A0 (en) * 2001-11-06 2004-08-31 Novartis Ag Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination

Also Published As

Publication number Publication date
EE200800070A (et) 2009-02-16
WO2008002634A1 (en) 2008-01-03
CA2654936A1 (en) 2008-01-03
TR200809829T1 (tr) 2009-06-22
US20090281159A1 (en) 2009-11-12
US20110124701A1 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
MX2013004491A (es) Boronatos como inhibidores de arginasa.
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
GEP20166443B (en) Heterocyclic compound and use thereof
UA106748C2 (uk) Похідні проліну як інгібітори катепсину
MX2010008523A (es) Inhibidores macrociclicos de serina proteasa.
MX341212B (es) Inhibidor de bromodominio de benzodiazepina.
WO2008011131A3 (en) Amide compounds
NZ585460A (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
IN2012DN00971A (es)
UA100250C2 (uk) Інгібітори реплікації вірусу імунодефіциту людини
UA104137C2 (ru) Пиридилсодержащие ингибиторы передачи сигнала через белок hedgehog
WO2010003475A8 (de) Neue pyrrolidinderivate als metap-2 inhibitoren
MX337575B (es) Compuestos de sulfona y métodos para lafabricación y uso de éstos.
GEP20156309B (en) Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
NZ595572A (en) Inhibitors of pi3 kinase and / or mtor
TN2011000291A1 (en) Purine compounds
GEP20125511B (en) Mapk/erk kinase inhibitors
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
MY153766A (en) Derivatised proline containing peptide organic compounds as protease inhibitors
MX2009010485A (es) Derivados de imidazolidinacarboxamida como inhibidores de lipasas y fosfolipasas.
MX2012004780A (es) Inhibidores de akt.
MX2010008460A (es) Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
MX2009006473A (es) Inhibidores de receptor vainilloide de bencimidazol.

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal